Saturday 17 October 2026
Export MSPR’s income statement to Excel — free account
MSP Recovery, Inc.
MSPR Healthcare Health Information Services
MSP Recovery, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $18.2 million, up 136.8% from fiscal 2023. In the quarter to September 2025, revenue fell 94.6%, EPS grew 39.8% and free cash flow grew 60.9%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.
0.00
0.00
NaN
Follow MSPR
| Older periods | Dec '24 | Mar '25 | Jun '25 | Sep '25 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.12 | 0.35 | 0.51 | 0.15 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
1.31 | (0.64) | (0.81) | (0.42) | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
41.28 | 28.08 | 28.62 | 27.10 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(46.73) | (17.36) | (18.44) | (15.35) | |
EV/FCF |
(39.97) | (15.30) | (16.28) | (13.26) | |
Quick Ratio |
0.01 | 0.02 | 0.01 | 0.00 | |
Current Ratio |
0.01 | 0.02 | 0.01 | 0.01 | |
Net Debt/EBITDA |
(0.99) | (43.92) | (62.22) | (53.04) | |
Debt/Assets |
39.78% | 20.69% | 22.54% | 17.16% | |
Debt/Equity |
(5.94) | (1.03) | (0.62) | (0.32) | |
Asset Turnover |
0.01 | 0.01 | 0.01 | 0.00 | |
Operating CF/Net income |
(0.01) | 0.06 | 0.06 | 0.02 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Coverage |
(7.75) | (1.07) | (1.00) | (0.95) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
61.70% | 635.36% | 818.84% | 1,999.49% | |
Intangible Assets out of Total Assets |
0.99 | 0.99 | 0.99 | 0.99 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
(894.27) | (468.78) | (332.61) | (1,674.02) | |
Graham Number |
10,950.46 | 9,704.83 | 10,685.64 | 9,340.13 | |
Earnings Yield |
(37,350.72%) | (66,934.04%) | (60,572.60%) | (513,790.80%) | |
Free Cash Flow Yield |
(829.39%) | (524.18%) | (342.18%) | (1,403.72%) | |
Revenue per Share |
57.64 | 1.62 | 0.76 | 0.16 | |
Operating CF per Share |
12.10 | (13.96) | (12.06) | (2.69) | |
Capex per Share |
(2.55) | (0.32) | 0.00 | 0.00 | |
Free Cash Flow per Share |
9.55 | (14.27) | (12.06) | (2.69) | |
Cash per Share |
86.21 | 17.61 | 5.69 | 1.44 | |
Shareholders Equity per Share |
(897.96) | (703.47) | (861.05) | (667.82) | |
Interest Debt per Share |
0.01 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(897.96) | (703.47) | (861.05) | (667.82) | |
Free Cash Flow |
1.37 | (7.35) | (8.46) | (3.40) | |
Working Capital |
(1,249.84) | (509.15) | (555.22) | (707.50) | |
Capital Expenditures |
(0.36) | (0.16) | 0.00 | 0.00 | |
Net Current Asset Value |
(2,032.02) | (2,147.49) | (2,270.24) | (2,391.80) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.04 | 0.19 | 0.00 | 0.00 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
1.45 | 1.40 | 1.40 | 2.94 | |
Average Payables |
10.11 | 12.93 | 12.12 | 11.45 | |
Average Assets |
2,539.54 | 2,417.00 | 2,291.61 | 2,169.99 | |
Average Common Equity |
645.36 | 440.50 | 214.99 | 1.30 |
Columns are period end dates